Viewing Study NCT00003967


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-25 @ 10:58 PM
Study NCT ID: NCT00003967
Status: COMPLETED
Last Update Posted: 2013-05-27
First Post: 1999-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CDR0000067168
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View